UPDATE: Morgan Stanley Downgrades CIT Group to Equal-Weight on Fewer Catalysts Outstanding
Morgan Stanley downgraded CIT Group (NYSE: CIT) from Overweight to Equal-weight and maintained a $46.00 price target.
Morgan Stanley said, "Risk-reward skew looks more balanced; we see fewer NT catalysts to drive CIT meaningfully higher. CIT shares are up 18% from lows post 3Q12 earnings as the company has achieved several key milestones to achieving their long-term targets, most importantly the elimination of more than $15B of high-cost debt and growing deposits to 31% of funding. Next catalysts for the stock include approval of CIT's capital plan, removal of the written agreement, and potential acquisitions (as indicated by mangement)."
CIT Group closed at $42.71 on Wednesday.
Latest Ratings for CIT
|Mar 2017||Morgan Stanley||Initiates Coverage On||Equal-Weight|
|Nov 2016||BMO Capital||Downgrades||Market Perform||Underperform|
|Nov 2016||Stephens & Co.||Initiates Coverage On||Equal-Weight|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.